Temporal Trends of β-haemolytic Streptococcal Osteoarticular Infections in Western Norway

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2016 Oct 8

PMID 27716100

Citations 9

Authors

Oddvar Oppegaard

Steinar Skrede

Haima Mylvaganam

Bard Reiakvam Kittang

Affiliations

Soon will be listed here.

Abstract

Background: Beta-haemolytic streptococci are important contributors to the global burden of osteoarticular infections (OAI). Knowledge on the disease traits specific for streptococcal OAI, however, remains scarce. We wished to explore temporal trends of OAI caused by Group A Streptococci (GAS), Group B Streptococci (GBS) and Group C and G Streptococci (GCGS), and furthermore, to describe the associated host and pathogen characteristics.

Methods: All cases of microbiologically verified β-haemolytic streptococcal OAI in Health Region Bergen, Norway, in the period 1999-2013 were retrospectively identified. Clinical data were extracted from medical records. Microbial isolates were submitted to antibiotic susceptibility testing and molecular typing.

Results: A total of 24 GAS, 45 GBS and 42 GCGS acute OAI were identified. The cumulative incidence of GCGS OAI, but not GAS or GBS OAI, increased significantly from the first to the last 5-year period (IRR 5.7, p = 0.0003), with the annual incidence peaking at 1.9/100 000 in 2013. GAS OAI generally produced the most acute and severe clinical presentation, whereas GBS and GCGS predominantly affected the elderly, and were significantly associated with the presence of host risk factors of systemic and focal origin, respectively.

Conclusions: We found a significantly increasing incidence of GCGS OAI, likely related to the presence of host susceptibility factors, including prosthetic material and pre-existing joint disease. With an increasing application of therapeutic and diagnostic bone and joint procedures, the rising trend of OAI caused by GCGS is likely to continue. Sustained epidemiological attentiveness to GCGS seems warranted.

Citing Articles

Integrative genomic, virulence, and transcriptomic analysis of emergent subspecies (SDSE) type isolates causing human infections.

Eraso J, Olsen R, Long S, Gadd R, Boukthir S, Faili A mBio. 2024; 15(11):e0257824.

PMID: 39417630 PMC: 11559094. DOI: 10.1128/mbio.02578-24.

Genomic epidemiology of subsp. strains causing invasive disease in Norway during 2018.

Kaci A, Jonassen C, Skrede S, Sivertsen A, Steinbakk M, Oppegaard O Front Microbiol. 2023; 14:1171913.

PMID: 37485526 PMC: 10361778. DOI: 10.3389/fmicb.2023.1171913.

Analysis of the Genomics and Mouse Virulence of an Emergent Clone of Streptococcus dysgalactiae Subspecies .

Beres S, Olsen R, Long S, Eraso J, Boukthir S, Faili A Microbiol Spectr. 2023; :e0455022.

PMID: 36971562 PMC: 10100674. DOI: 10.1128/spectrum.04550-22.

Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999-2021.

Oppegaard O, Glambek M, Skutlaberg D, Skrede S, Sivertsen A, Kittang B Emerg Infect Dis. 2023; 29(2):260-267.

PMID: 36692331 PMC: 9881787. DOI: 10.3201/eid2902.221218.

Transcriptomic analysis of Streptococcus agalactiae periprosthetic joint infection.

Cho H, Masters T, Greenwood-Quaintance K, Johnson S, Jeraldo P, Chia N Microbiologyopen. 2021; 10(6):e1256.

PMID: 34964296 PMC: 8678771. DOI: 10.1002/mbo3.1256.

References

Choi S, Rasmussen M, Hubisz M, Gronau I, Stanhope M, Siepel A . Replacing and additive horizontal gene transfer in Streptococcus. Mol Biol Evol. 2012; 29(11):3309-20. PMC: 3472495. DOI: 10.1093/molbev/mss138. View

Dubost J, Soubrier M, De Champs C, Ristori J, Sauvezie B . Streptococcal septic arthritis in adults. A study of 55 cases with a literature review. Joint Bone Spine. 2004; 71(4):303-11. DOI: 10.1016/S1297-319X(03)00122-2. View

Imohl M, Reinert R, Ocklenburg C, van der Linden M . Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol. 2010; 58(3):389-96. DOI: 10.1111/j.1574-695X.2010.00652.x. View

Schattner A, Vosti K . Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore). 1998; 77(2):122-39. DOI: 10.1097/00005792-199803000-00004. View

Colavite P, Sartori A . Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis. 2014; 20:19. PMC: 4017707. DOI: 10.1186/1678-9199-20-19. View

Kommedal O, Kvello K, Skjastad R, Langeland N, Wiker H . Direct 16S rRNA gene sequencing from clinical specimens, with special focus on polybacterial samples and interpretation of mixed DNA chromatograms. J Clin Microbiol. 2009; 47(11):3562-8. PMC: 2772595. DOI: 10.1128/JCM.00973-09. View

. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993; 269(3):390-1. View

Geirsson A, Statkevicius S, Vikingsson A . Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections. Ann Rheum Dis. 2007; 67(5):638-43. PMC: 2563417. DOI: 10.1136/ard.2007.077131. View

Lambertsen L, Ingels H, Schonheyder H, Hoffmann S . Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011. Clin Microbiol Infect. 2013; 20(4):O216-23. PMC: 4232002. DOI: 10.1111/1469-0691.12378. View

10.

Harris P, Siew D, Proud M, Buettner P, Norton R . Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clin Microbiol Infect. 2010; 17(8):1216-22. DOI: 10.1111/j.1469-0691.2010.03427.x. View

11.

Lim S, Pannikath D, Nugent K . A retrospective study of septic arthritis in a tertiary hospital in West Texas with high rates of methicillin-resistant Staphylococcus aureus infection. Rheumatol Int. 2015; 35(7):1251-6. DOI: 10.1007/s00296-014-3206-9. View

12.

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4):530-8. DOI: 10.1007/s00134-003-1662-x. View

13.

Kreikemeyer B, Nakata M, Oehmcke S, Gschwendtner C, Normann J, Podbielski A . Streptococcus pyogenes collagen type I-binding Cpa surface protein. Expression profile, binding characteristics, biological functions, and potential clinical impact. J Biol Chem. 2005; 280(39):33228-39. DOI: 10.1074/jbc.M502896200. View

14.

Kennedy N, Chambers S, Nolan I, Gallagher K, Werno A, Browne M . Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population. J Rheumatol. 2015; 42(12):2392-7. DOI: 10.3899/jrheum.150434. View

15.

Jonsson I, Pietrocola G, Speziale P, Verdrengh M, Tarkowski A . Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by Streptococcus agalactiae. J Infect Dis. 2005; 192(8):1456-64. DOI: 10.1086/491478. View

16.

Newman J . Review of septic arthritis throughout the antibiotic era. Ann Rheum Dis. 1976; 35(3):198-205. PMC: 1006541. DOI: 10.1136/ard.35.3.198. View

17.

Bergseng H, Rygg M, Bevanger L, Bergh K . Invasive group B streptococcus (GBS) disease in Norway 1996-2006. Eur J Clin Microbiol Infect Dis. 2008; 27(12):1193-9. DOI: 10.1007/s10096-008-0565-8. View

18.

Vlaminckx B, Mascini E, Schellekens J, Schouls L, Paauw A, Fluit A . Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol. 2003; 41(11):4941-9. PMC: 262503. DOI: 10.1128/JCM.41.11.4941-4949.2003. View

19.

Osmon D, Berbari E, Berendt A, Lew D, Zimmerli W, Steckelberg J . Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2012; 56(1):e1-e25. DOI: 10.1093/cid/cis803. View

20.

Kittang B, Langeland N, Mylvaganam H . Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. APMIS. 2008; 116(6):457-64. DOI: 10.1111/j.1600-0463.2008.00976.x. View